HomeInsightsStock Comparison

Morepen Laboratories Ltd vs Vivanza Biosciences Ltd Stock Comparison

Morepen Laboratories Ltd vs Vivanza Biosciences Ltd Stock Comparison

Last Updated on: Jul 06, 2025

Key Highlights

  • The Latest Trading Price of Morepen Laboratories Ltd is ₹ 65.24 as of 04 Jul 15:30.
  • The P/E Ratio of Morepen Laboratories Ltd changed from 12.7 on March 2020 to 22.4 on March 2024 . This represents a CAGR of 12.02% over 5 yearsThe P/E Ratio of Vivanza Biosciences Ltd changed from 687.4 on March 2021 to 48.5 on March 2024 . This represents a CAGR of -48.46% over 4 years.
  • The Market Cap of Morepen Laboratories Ltd changed from ₹ 429.13 crore on March 2020 to ₹ 2149 crore on March 2024 . This represents a CAGR of 38.03% over 5 yearsThe Market Cap of Vivanza Biosciences Ltd changed from ₹ 52.24 crore on March 2021 to ₹ 27.16 crore on March 2024 . This represents a CAGR of -15.09% over 4 years.
  • The revenue of Morepen Laboratories Ltd for the Mar '25 is ₹ 470.46 crore as compare to the Dec '24 revenue of ₹ 458.12 crore. This represent the growth of 2.69% The revenue of Vivanza Biosciences Ltd for the Mar '25 is ₹ 0.53 crore as compare to the Dec '24 revenue of ₹ 1.51 crore. This represent the decline of -64.9%.
  • The ebitda of Morepen Laboratories Ltd for the Mar '25 is ₹ 46.85 crore as compare to the Dec '24 ebitda of ₹ 41.48 crore. This represent the growth of 12.95% The ebitda of Vivanza Biosciences Ltd for the Mar '25 is ₹ -0.91 crore as compare to the Dec '24 ebitda of ₹ 0.13 crore. This represent the decline of -800%.
  • The net profit of Morepen Laboratories Ltd changed from ₹ 14.63 crore to ₹ 20.31 crore over 8 quarters. This represents a CAGR of 17.82% The net profit of Vivanza Biosciences Ltd changed from ₹ 0.49 crore to ₹ -1 crore over 8 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Morepen Laboratories Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Vivanza Biosciences Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Morepen Laboratories Ltd

  • Morepen Laboratories Limited is an India-based pharmaceutical company.
  • Its products include Loratadine, Montelukast Sodium, Atorvastatin Calcium and Sultamicillin.
  • The company markets formulation products in various therapeutic categories, such as antibiotics, gastrointestinal, respiratory, analgesic, antiallergic and neuropsychiatry with brands, such as Saltum, Saltumax, Cefpopen, Cefpen-S, Dom-DT, Acifix, Rabipen- DSR and Montelast.
  • It has new products added to the therapeutic categories, including Kilbac, Ducal D, Aclomore and Montelast-L. The company has three state-of-the-art manufacturing plants in the northern state of Himachal Pradesh (HP) in India.
  • The main plant at Parwanoo is inspected and approved by United States Food and Drug Administration (USFDA) for production of Loratadine, which is the best selling anti-allergy drug globally.

About Vivanza Biosciences Ltd

  • Vivanza Biosciences Limited(Previously known Ivee Injectaa Limited) was established in March, 1982 as a Private Limited Company and was converted into a Public Limited Company in May, 1992.
  • Due to recessionary trends which lead to difficult business conditions in the year 1999-2000, the parenteral industry suffered a setback.
  • As a result of this, the name of the Company was changed from Ivee Injectaa Limited to Vivanza Biosciences Limited in 2015. The Company is focused in commercializing novel and generic pharmaceuticals, offering patients better, safe and more accessible medicines.
  • It is presently engaged in the business of Pharmaceutical Products and Pharma Products. Head quartered in Gujarat, India, Company came into existence in April 2016 to further spread its wings in global market with global quality pharmaceutical products at competitive pricing system.

Morepen Laboratories Ltd News Hub

News

Morpen Labs incorporates subsidiary in Dubai

The newly formed wholly owned subsidiary namely Morepen Labs ' FZCO, will trade in pharmac...

Read more

19 Jun 2025 08:44

News

Board of Morepen Laboratories approves availing of working capital loan of Rs 50 cr

The Board of Morepen Laboratories at its meeting held on 23 May 2025 has approved inter-al...

Read more

23 May 2025 10:25

News

Board of Morepen Laboratories notes incorporation of step-down subsidiary in Dubai

The Board of Morepen Laboratories at its meeting held on 12 May 2025 has noted the decisio...

Read more

12 May 2025 18:29

News

Board of Morepen Laboratories recommends Final Dividend

Morepen Laboratories announced that the Board of Directors of the Company at its meeting h...

Read more

12 May 2025 16:11

News

Morepen Laboratories to announce Quarterly Result

Morepen Laboratories will hold a meeting of the Board of Directors of the Company on 12 Ma...

Read more

06 May 2025 11:55

News

Morepen receives CDSCO nod to conduct BE studies for Resmetirom

Morepen Laboratories has got clearance from Subject Expert Committee (SEC) of Central Drug...

Read more

29 Apr 2025 09:07

Vivanza Biosciences Ltd News Hub

News

Vivanza Biosciences to table results

Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 12 May...

Read more

08 May 2025 11:19

News

Vivanza Biosciences announces board meeting date

Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 12 May...

Read more

07 May 2025 11:35

News

Vivanza Biosciences to discuss results

Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 31 Jan...

Read more

25 Jan 2025 10:18

News

Vivanza Biosciences to declare Quarterly Result

Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 17 Oct...

Read more

11 Oct 2024 10:17

News

Vivanza Biosciences to announce Quarterly Result

Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 8 Augu...

Read more

03 Aug 2024 17:02

News

Vivanza Biosciences to convene AGM

Vivanza Biosciences announced that the 42nd Annual General Meeting (AGM) of the company wi...

Read more

08 Jul 2024 10:49

SWOT Analysis Of Vivanza Biosciences Ltd

Strength

2

S

Weakness

3

W

Opportunity

1

O

Threats

0

T

SWOT Analysis Of Morepen Laboratories Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Vivanza Biosciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Morepen Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Morepen Laboratories Ltd and Vivanza Biosciences Ltd

Which company has a larger market capitalization, Morepen Laboratories Ltd or Vivanza Biosciences Ltd?

Market cap of Morepen Laboratories Ltd is 3,574 Cr while Market cap of Vivanza Biosciences Ltd is 8 Cr

What are the key factors driving the stock performance of Morepen Laboratories Ltd and Vivanza Biosciences Ltd?

The stock performance of Morepen Laboratories Ltd and Vivanza Biosciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Morepen Laboratories Ltd and Vivanza Biosciences Ltd?

As of July 6, 2025, the Morepen Laboratories Ltd stock price is INR ₹65.24. On the other hand, Vivanza Biosciences Ltd stock price is INR ₹2.17.

How do dividend payouts of Morepen Laboratories Ltd and Vivanza Biosciences Ltd compare?

To compare the dividend payouts of Morepen Laboratories Ltd and Vivanza Biosciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions